Bio-Medical Applications of Ohio, INC.
Bio-Medical Applications of Ohio, INC. was paid $4.58M by Medicaid between Jan 2018 and Oct 2024, across 51 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 90% of everything it billed.
COLUMBUS, OH 43215
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Ohio
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,546 | $517K | |
| 2019 | 65,348 | $776K | |
| 2020 | 63,516 | $768K | |
| 2021 | 67,630 | $727K | |
| 2022 | 56,897 | $803K | |
| 2023 | 53,237 | $465K | |
| 2024incomplete | 46,413 | $527K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 90% | 52,208 | 4,639 | $4.11M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 8.5% | 6,184 | 3,356 | $390K |
| A4657 | Syringe, with or without needle, each | <1% | 100,670 | 4,726 | $26K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 13,579 | 2,891 | $24K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | <1% | 9,658 | 1,130 | $23K |
| J1270 | Injection, doxercalciferol, 1 mcg | <1% | 38,493 | 3,537 | $5K |
| 90732 | <1% | 41 | 39 | $665.88 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 66,308 | 3,576 | $617.67 |
| A6216 | Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 10,318 | 1,053 | $506.20 |
| 90740 | <1% | 29 | 27 | $267.36 | |
| 83970 | <1% | 4,714 | 4,302 | $247.55 | |
| G0008 | Administration of influenza virus vaccine | <1% | 232 | 215 | $81.67 |
39 more codes
| 85018 | <1% | 18,290 | $67.94 | |
| 84520 | <1% | 12,316 | $61.61 | |
| 90686 | <1% | 70 | $57.09 | |
| 84100 | <1% | 7,332 | $36.24 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 37 | $26.26 |
| 82310 | <1% | 7,704 | $24.96 | |
| 82040 | <1% | 4,602 | $23.15 | |
| 84132 | <1% | 7,082 | $20.71 | |
| 90688 | <1% | 48 | $17.84 | |
| 82962 | <1% | 83 | $12.05 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,537 | $11.87 |
| 87340 | <1% | 4,562 | $11.14 | |
| 83550 | <1% | 4,446 | $10.41 | |
| 83540 | <1% | 4,654 | $9.58 | |
| 82565 | <1% | 4,626 | $8.93 | |
| 82108 | <1% | 466 | $7.64 | |
| 82947 | <1% | 2,331 | $7.59 | |
| 82374 | <1% | 974 | $6.41 | |
| 84295 | <1% | 1,007 | $6.41 | |
| 84155 | <1% | 2,506 | $6.41 | |
| 82435 | <1% | 979 | $6.41 | |
| 82728 | <1% | 3,217 | $6.24 | |
| 82746 | <1% | 403 | $4.41 | |
| J3490 | Unclassified drugs | <1% | 11,517 | $3.83 |
| 86704 | <1% | 311 | $3.61 | |
| 86706 | <1% | 777 | $3.22 | |
| 80051 | <1% | 3,163 | $3.13 | |
| 83735 | <1% | 934 | $2.01 | |
| 84075 | <1% | 1,483 | $1.72 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 472 | $0.64 |
| 80061 | Lipid panel | 0% | 265 | $0.00 |
| 90682 | 0% | 43 | $0.00 | |
| 90662 | 0% | 12 | $0.00 | |
| 84466 | 0% | 138 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 528 | $0.00 |
| 90677 | 0% | 14 | $0.00 | |
| 86803 | 0% | 54 | $0.00 | |
| 82607 | 0% | 141 | $0.00 | |
| G0010 | Administration of hepatitis b vaccine | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.